Two PML Deaths Confirmed in Patients Taking Raptiva

Drug Industry Daily
Two patients who took Genentech’s psoriasis drug Raptiva for more than three years have died of progressive multifocal leukoencephalopathy (PML), a rare brain infection, and a third person who may have had the disease died of unknown causes.

To View This Article:


Subscribe To Drug Industry Daily